BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10810414)

  • 1. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
    Hsu CH; Chen MY; Cheng AL
    Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel for AIDS-associated Kaposi's sarcoma.
    Dhillon T; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
    Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
    Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.
    Silvestris N; Galetta D; Colucci G
    Anticancer Res; 2009 Feb; 29(2):675-6. PubMed ID: 19331220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer agents. A new treatment for Kaposi's sarcoma?
    TreatmentUpdate; 2002; 14(7):6-8. PubMed ID: 12400501
    [No Abstract]   [Full Text] [Related]  

  • 6. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.
    Brambilla L; Romanelli A; Bellinvia M; Ferrucci S; Vinci M; Boneschi V; Miedico A; Tedeschi L
    Br J Dermatol; 2008 Jun; 158(6):1339-44. PubMed ID: 18363766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy.
    Baskan EB; Tunali S; Adim SB; Kiyici M; Ali R
    Int J Dermatol; 2006 Dec; 45(12):1441-3. PubMed ID: 17184252
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
    Welles L; Saville MW; Lietzau J; Pluda JM; Wyvill KM; Feuerstein I; Figg WD; Lush R; Odom J; Wilson WH; Fajardo MT; Humphrey RW; Feigal E; Tuck D; Steinberg SM; Broder S; Yarchoan R
    J Clin Oncol; 1998 Mar; 16(3):1112-21. PubMed ID: 9508198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
    J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of classical type Kaposi's sarcoma with paclitaxel.
    Chao SC; Lee JY; Tsao CJ
    Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
    Bernstein ZP; Chanan-Khan A; Miller KC; Northfelt DW; Lopez-Berestein G; Gill PS
    Cancer; 2002 Dec; 95(12):2555-61. PubMed ID: 12467070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
    Remick SC; Reddy M; Ekman K; Vyzula R; Hilstro J; Horton J
    J Infus Chemother; 1996; 6(2):92-6. PubMed ID: 8809657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
    Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
    Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma.
    Kobayashi M; Takaori-Kondo A; Shindo K; Mizutani C; Ishikawa T; Uchiyama T
    Intern Med; 2002 Dec; 41(12):1209-12. PubMed ID: 12521218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of recurrent, classical Kaposi's sarcoma using multiple paclitaxel treatments.
    Osawa R; Kato N; Yanagi T; Yamane N
    Acta Derm Venereol; 2007; 87(5):435-6. PubMed ID: 17721656
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of AIDS-related Kaposi's sarcoma.
    Northfelt DW; Kahn JO; Volberding PA
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):297-310. PubMed ID: 2022595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
    Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
    Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of relapsed visceral Kaposi's sarcoma with bilateral chylothoraces successfully treated with paclitaxel.
    Natarajan P; Miller A
    Int J STD AIDS; 2015 Jul; 26(8):605-9. PubMed ID: 25122577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
    Paredes J; Kahn JO; Tong WP; Feldstein ML; Lin S; Bennett JM; Metroka CE; Ratner L; Krown SE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):138-44. PubMed ID: 7749790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.